(0.12%) 5 252.50 points
(0.08%) 39 673 points
(0.18%) 18 288 points
(0.40%) $78.57
(1.42%) $2.28
(-0.83%) $2 355.40
(-0.44%) $28.38
(0.11%) $1 008.30
(-0.05%) $0.928
(0.22%) $10.86
(0.02%) $0.799
(-0.92%) $91.81
Quarter results tomorrow
(bmo 2024-05-14)
Expected move: +/- 14.84%
Live Chart Being Loaded With Signals
Xilio Therapeutics, Inc., a clinical-stage biotechnology company, develops immunotherapies to improve the immune system of cancer patients. Its checkpoint inhibitor program includes XTX101, a clinical-stage, tumor-selective anti-CTLA-4 mAb that is in Phase 1/2 clinical trials in patients with solid tumors...
Stats | |
---|---|
Today's Volume | 230 498 |
Average Volume | 1.24M |
Market Cap | 43.56M |
EPS | $0 ( 2024-04-04 ) |
Next earnings date | ( $-0.300 ) 2024-05-14 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.420 |
ATR14 | $0.0160 (1.38%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-05-01 | Luptakova Katarina | Buy | 59 333 | Stock Option (right to buy) |
2024-05-01 | Brennan Kevin M. | Buy | 20 000 | Stock Option (right to buy) |
2024-05-01 | Frankenfield Christopher James | Buy | 208 000 | Stock Option (right to buy) |
2024-05-01 | Russo Rene | Buy | 474 000 | Stock Option (right to buy) |
2024-04-02 | Gilead Sciences, Inc. | Buy | 485 250 | Common Stock |
INSIDER POWER |
---|
92.68 |
Last 95 transactions |
Buy: 17 386 240 | Sell: 51 387 838 |
Volume Correlation
Xilio Therapeutics, Inc. Correlation
10 Most Positive Correlations | |
---|---|
XFOR | 0.899 |
DSGN | 0.894 |
PFSW | 0.888 |
IDN | 0.888 |
CTIC | 0.879 |
CRON | 0.877 |
CDXC | 0.876 |
AMRB | 0.872 |
NWLI | 0.87 |
MU | 0.866 |
10 Most Negative Correlations | |
---|---|
LIAN | -0.832 |
SBNYP | -0.819 |
TUEM | -0.819 |
STAB | -0.818 |
LUNA | -0.817 |
ATAK | -0.813 |
CFV | -0.812 |
BTTX | -0.806 |
AHPI | -0.802 |
ISPC | -0.801 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Xilio Therapeutics, Inc. Correlation - Currency/Commodity
Xilio Therapeutics, Inc. Financials
Annual | 2023 |
Revenue: | $0 |
Gross Profit: | $-1.90M (0.00 %) |
EPS: | $-2.78 |
FY | 2023 |
Revenue: | $0 |
Gross Profit: | $-1.90M (0.00 %) |
EPS: | $-2.78 |
FY | 2022 |
Revenue: | $0 |
Gross Profit: | $-1.85M (0.00 %) |
EPS: | $-3.19 |
FY | 2021 |
Revenue: | $0.00 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-13.52 |
Financial Reports:
No articles found.
Xilio Therapeutics, Inc.
Xilio Therapeutics, Inc., a clinical-stage biotechnology company, develops immunotherapies to improve the immune system of cancer patients. Its checkpoint inhibitor program includes XTX101, a clinical-stage, tumor-selective anti-CTLA-4 mAb that is in Phase 1/2 clinical trials in patients with solid tumors. The company also develops cytokine programs, which comprises XTX202, a modified form of IL-2; XTX301, an IL-12 product candidate; and XTX401, an IL-15 product candidate that are masked with a protein domain to prevent binding activity until cleaved off by tumor microenvironment (TME)-associated proteases. Xilio Therapeutics, Inc. was founded in 2016 and is headquartered in Waltham, Massachusetts.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators